IVD（体外診断）市場 - 製品別、サービス別、技術別、検体別、テストタイプ別、用途別：世界市場規模・市場予測レポート（〜2029年）

1194億USD (2029年)

6.9% (2024年～2029年)

Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Qiagen N.V., QuidelOrtho Corporation, DiaSorin S.p.A., Illumina, Inc., Hologic, Inc., Revvity, Griffols, Werfen, Devyser, Chembio Diagnostics, Inc., Surmodics, Inc., Menarini Silicon Biosystems, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics, Inc., Merck KGaA, Caris Life Sciences, Inc, Cellabs, J. Mitra & Co. Pvt. Ltd., Epitope Diagnostics, Boster Biological Technology, Enzo Biochem, Genetic Signatures, Savyon Diagnostics, Trivitron Healthcare, mdxhealth, Creative Diagnostics, InBios International, Inc., Maccura Biotechnology Co., Ltd., Vela Diagnostics, ARKRAY, Inc.

加齢に伴う疾患の増加、感染症の早期検出の重要性、分子診断技術の応用の拡大